Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists

Aún no traducido Aún no traducido
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2009
The purpose of this study is to evaluate the safety and efficacy of induction therapy with Thymoglobulin in comparison with IL2 receptor antagonists (daclizumab or basiliximab).
Epistemonikos ID: 620288d7760f5741f7fca738cd3ce4e5d19acdc4
First added on: Oct 29, 2018